EuroSpA publication 4.3Comparing DAPSA, DAPSA28, and DAS28-CRP in PatientsWith Psoriatic Arthritis Initiating a First Tumor NecrosisFactor Inhibitor Across Nine European CountriesClick here to access full article Anne Oeraker Mikkelsen2024-08-20T12:31:39+02:00